QIAGEN Total Liabilities 2010-2023 | QGEN
QIAGEN total liabilities from 2010 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
- QIAGEN total liabilities for the quarter ending March 31, 2023 were $2.718B, a 7.69% decline year-over-year.
- QIAGEN total liabilities for 2022 were $2.821B, a 7.52% decline from 2021.
- QIAGEN total liabilities for 2021 were $3.05B, a 0.7% decline from 2020.
- QIAGEN total liabilities for 2020 were $3.072B, a 13.81% increase from 2019.
QIAGEN Annual Total Liabilities
(Millions of US $) |
| 2022 |
$2,821 |
| 2021 |
$3,050 |
| 2020 |
$3,072 |
| 2019 |
$2,699 |
| 2018 |
$3,113 |
| 2017 |
$2,498 |
| 2016 |
$1,701 |
| 2015 |
$1,611 |
| 2014 |
$1,796 |
| 2013 |
$1,365 |
| 2012 |
$1,363 |
| 2011 |
$1,172 |
| 2010 |
$1,438 |
| 2009 |
$1,505 |
QIAGEN Quarterly Total Liabilities
(Millions of US $) |
| 2023-03-31 |
$2,718 |
| 2022-12-31 |
$2,821 |
| 2022-09-30 |
$3,189 |
| 2022-06-30 |
$2,871 |
| 2022-03-31 |
$2,944 |
| 2021-12-31 |
$3,050 |
| 2021-09-30 |
$3,030 |
| 2021-06-30 |
$2,930 |
| 2021-03-31 |
$2,913 |
| 2020-12-31 |
$3,072 |
| 2020-09-30 |
$3,060 |
| 2020-06-30 |
$2,674 |
| 2020-03-31 |
$2,689 |
| 2019-12-31 |
$2,699 |
| 2019-09-30 |
$2,675 |
| 2019-06-30 |
$2,750 |
| 2019-03-31 |
$2,814 |
| 2018-12-31 |
$3,113 |
| 2018-09-30 |
$2,772 |
| 2018-06-30 |
$2,785 |
| 2018-03-31 |
$2,525 |
| 2017-12-31 |
$2,498 |
| 2017-09-30 |
$2,530 |
| 2017-06-30 |
$2,051 |
| 2017-03-31 |
$1,638 |
| 2016-12-31 |
$1,701 |
| 2016-09-30 |
$1,662 |
| 2016-06-30 |
$1,492 |
| 2016-03-31 |
$1,495 |
| 2015-12-31 |
$1,611 |
| 2015-09-30 |
$1,639 |
| 2015-06-30 |
$1,594 |
| 2015-03-31 |
$1,691 |
| 2014-12-31 |
$1,796 |
| 2014-09-30 |
$1,748 |
| 2014-06-30 |
$1,809 |
| 2014-03-31 |
$1,754 |
| 2013-12-31 |
$1,365 |
| 2013-09-30 |
$1,379 |
| 2013-06-30 |
$1,381 |
| 2013-03-31 |
$1,343 |
| 2012-12-31 |
$1,363 |
| 2012-09-30 |
$1,245 |
| 2012-06-30 |
$1,235 |
| 2012-03-31 |
$1,163 |
| 2011-12-31 |
$1,172 |
| 2011-09-30 |
$1,364 |
| 2011-06-30 |
$1,404 |
| 2011-03-31 |
$1,422 |
| 2010-12-31 |
$1,438 |
| 2010-09-30 |
$1,460 |
| 2010-06-30 |
$1,433 |
| 2010-03-31 |
$1,469 |
| 2009-12-31 |
$1,505 |
| 2009-09-30 |
$1,526 |
| 2009-06-30 |
$1,436 |
| 2009-03-31 |
$1,370 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.584B |
$2.142B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
